Women are catching up with men’s drug use.

MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.

Theranos was dissolved years ago, and its CEO, Elizabeth Holmes, is in prison, but the company’s patents based on bad science live on – a stark example of the persistence of faulty information.

Drug development takes a great deal of time, money and effort. While future profits play a big factor in which diseases gets prioritized, advocacy and research incentives can also tilt the scale.

Ultrasound can guide "microvehicles" through blood vessels in the brain. Researchers hope this will lead to more precise drug delivery.

MIT and MGH researchers design a local, gel-based drug-delivery platform that may provoke a system-wide immune response to metastatic tumors.

When just one of the thousands of microRNAs in people go awry, it can cause diseases ranging from heart disease to cancer.

Core-shell structures made of hydrogel could enable more efficient uptake in the body.

The facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced